Rhythm Pharmaceuticals (RYTM) had the highest return between June 1, 2022 and August 30, 2022 by a mid-cap US stock, returning 539.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 8/30/2022 | 539.66% |
Axsome Therapeutics (AXSM) | 6/1/2022 - 8/30/2022 | 142.53% |
Verona Pharma PLC ADR (VRNA) | 6/1/2022 - 8/30/2022 | 118.54% |
New Oriental Education & Technology (EDU) | 6/1/2022 - 8/30/2022 | 117.86% |
Catalyst Pharmaceuticals (CPRX) | 6/1/2022 - 8/30/2022 | 91.31% |
Impinj (PI) | 6/1/2022 - 8/30/2022 | 90.25% |
Centrus Energy (LEU) | 6/1/2022 - 8/30/2022 | 87.04% |
Kymera Therapeutics (KYMR) | 6/1/2022 - 8/30/2022 | 85.86% |
Belite Bio Inc ADR (BLTE) | 6/1/2022 - 8/30/2022 | 78.94% |
Nuvalent (NUVL) | 6/1/2022 - 8/30/2022 | 77.98% |
TransMedics (TMDX) | 6/1/2022 - 8/30/2022 | 76.01% |
Global-E Online (GLBE) | 6/1/2022 - 8/30/2022 | 69.23% |
PTC Therapeutics (PTCT) | 6/1/2022 - 8/30/2022 | 68.72% |
Scholar Rock (SRRK) | 6/1/2022 - 8/30/2022 | 59.72% |
Privia Health (PRVA) | 6/1/2022 - 8/30/2022 | 58.29% |
Gitlab (GTLB) | 6/1/2022 - 8/30/2022 | 57.64% |
Calix (CALX) | 6/1/2022 - 8/30/2022 | 56.64% |
TG Therapeutics (TGTX) | 6/1/2022 - 8/30/2022 | 55.99% |
TAL Education (TAL) | 6/1/2022 - 8/30/2022 | 52.42% |
Enphase Energy (ENPH) | 6/1/2022 - 8/30/2022 | 52.24% |
Lyell Immunopharma (LYEL) | 6/1/2022 - 8/30/2022 | 51.57% |
Sarepta Therapeutics (SRPT) | 6/1/2022 - 8/30/2022 | 50.42% |
BridgeBio Pharma (BBIO) | 6/1/2022 - 8/30/2022 | 50.29% |
BioCryst Pharmaceuticals (BCRX) | 6/1/2022 - 8/30/2022 | 48.07% |
Extreme Networks (EXTR) | 6/1/2022 - 8/30/2022 | 46.15% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
